MT-201 Clinical Trials
2 recruitingDrug
Phase 21Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Crohn's DiseaseUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Mirador Therapeutics, Inc.140 enrolled66 locationsNCT07113522
Recruiting
Phase 1
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
Healthy Volunteer
Mirador Therapeutics, Inc.72 enrolled1 locationNCT07219368